TNFAIP3 (Tumor Necrosis Factor Alpha-Induced Protein 3), also known as A20, is a zinc finger protein that plays a critical role in regulating inflammation, cell survival, and immune homeostasis. As a dual-function deubiquitinase and E3 ubiquitin ligase, TNFAIP3 is a key negative regulator of NF-κB signaling and provides protection against excessive inflammatory responses in various neurodegenerative diseases. The protein was originally identified as a TNF-α-induced gene that protects cells from TNF-mediated cytotoxicity, hence the name "A20."
TNFAIP3 is essential for maintaining immune tolerance and preventing chronic inflammation. Its dysregulation is implicated in autoimmune diseases, inflammatory disorders, and neurodegenerative conditions where neuroinflammation plays a central role. The protein operates through multiple mechanisms, including deubiquitination of key signaling intermediates, ubiquitination-dependent protein degradation, and transcriptional repression of inflammatory genes.
| Property |
Value |
| Gene |
TNFAIP3 |
| UniProt |
P21580 |
| Molecular Weight |
~90 kDa (790 amino acids) |
| PDB Structures |
5O6Y, 6R3K, 4WBG, 4WBT |
| Subcellular Localization |
Cytoplasm, nucleus |
| Protein Family |
A20 family, OTU domain deubiquitinases |
| Aliases |
A20, TNFIP3, OTU domain containing 7 |
¶ Domain Structure
TNFAIP3 contains multiple functional domains:
- N-terminal OTU domain: Ovarian tumor (OTU) deubiquitinase domain (~370 aa) with specificity for K63-linked polyubiquitin chains
- Zinc finger domains: Seven C3HC4-type zinc fingers in the C-terminal region that mediate protein-protein interactions and E3 ubiquitin ligase activity
- Nuclear localization signals: Enable shuttling between cytoplasm and nucleus
This unique combination of enzymatic activities allows TNFAIP3 to regulate NF-κB signaling at multiple levels.
TNFAIP3 is a master regulator of NF-κB signaling through multiple mechanisms:
- Deubiquitinase activity: The OTU domain removes K63-linked ubiquitin chains from TRAF6, RIP1, and NEMO, key intermediates in NF-κB activation pathways
- Negative feedback loop: TNFAIP3 is itself induced by NF-κB, creating an autoregulatory feedback that limits inflammatory responses
- Signaling interruption: By deubiquitinating key signaling proteins, TNFAIP3 prevents downstream kinase activation
- Proteasomal degradation: The zinc finger domains enable K48-linked ubiquitination and degradation of signaling proteins
Beyond inflammation, TNFAIP3 promotes cell survival:
- Anti-apoptotic function: Inhibits caspase activation and apoptosis through NF-κB-dependent and independent mechanisms
- Stress response: Protects against various cellular stresses including DNA damage, oxidative stress, and endoplasmic reticulum stress
- Cell cycle regulation: Modulates cell cycle progression to prevent stress-induced cell death
TNFAIP3 is essential for immune cell function:
- Microglial activation: Regulates microglial phenotype and cytokine production in the brain
- TLR signaling: Modulates Toll-like receptor responses to pathogen-associated molecular patterns
- Cytokine production: Reduces production of proinflammatory cytokines including TNF-α, IL-1β, and IL-6
- Autoimmunity prevention: Maintains peripheral tolerance and prevents aberrant immune responses
TNFAIP3/A20 is critically involved in Alzheimer's disease pathogenesis:
- Chronic neuroinflammation: Reduced A20 expression in AD brains contributes to sustained microglial activation and proinflammatory cytokine production
- Amyloid-β response: Dysregulated inflammatory responses to Aβ plaques due to impaired A20 function
- Microglial priming: Loss of A20 leads to a hyper-reactive microglial phenotype that exacerbates neuronal damage
- NF-κB dysregulation: Impaired negative regulation of NF-κB in glial cells promotes chronic inflammation
- Therapeutic targeting: Restoring A20 function represents a potential therapeutic strategy for AD
- Dopaminergic neuron protection: A20 protects dopaminergic neurons from inflammatory damage
- Microglial activation: Modulates microglia-mediated neurotoxicity in the substantia nigra
- α-Synuclein pathology: Influences the inflammatory response to α-synuclein aggregates
- Mitochondrial dysfunction: May protect against mitochondrial stress in dopaminergic neurons
- Motor neuron survival: A20 protects motor neurons from inflammatory cell death
- Astrocyte reactivity: Regulates astrocyte-mediated neuroinflammation in ALS
- Glutamate excitotoxicity: May modulate excitotoxic pathways
- Demyelination: A20 dysfunction contributes to demyelinating pathology
- Autoimmune inflammation: Loss of A20 exacerbates adaptive immune responses
Targeting TNFAIP3 offers therapeutic opportunities:
- A20 enhancers: Small molecules that increase A20 expression or activity
- Gene therapy: Viral vector-mediated A20 delivery to the CNS
- NF-κB inhibitors: Exploiting A20-mediated pathways for anti-inflammatory effects
- Microglial modulation: Targeting A20 in microglia for neuroprotection
- Combination therapy: A20 modulation combined with other disease-modifying approaches
TNFAIP3 is associated with the following neurodegenerative and inflammatory diseases:
- TNFAIP3/A20 in inflammation and disease, Nat Rev Immunol (2012)
- A20: a multifunctional tool for disease therapy, Trends Immunol (2018)
- TNFAIP3 in Alzheimer's disease neuroinflammation, J Neurosci (2019)
- Microglial A20 and neuroprotection, Glia (2020)